Federal Circuit reverses infringement finding in Angiomax dispute

10-04-2017

Federal Circuit reverses infringement finding in Angiomax dispute

BrianAJackson / iStockphoto.com

The US Court of Appeals for the Federal Circuit has reversed a district court’s ruling of infringement in a patent dispute between The Medicines Company and Mylan.


Federal Circuit, patent, Angiomax, The Medicines Company, Mylan, ANDA, FDA

LSIPR